OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Autoimmunity is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Pulmonary and serum cytokine profiles of patients with anti-ARS and anti-MDA5 antibodies	368
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	224
Optimizing the tapering scheme of corticosteroid treatment for acute onset of autoimmune hepatitis	185
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	130
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis	122
Control of naive and effector CD4 T cell receptor repertoires by rheumatoid-arthritis-risk HLA alleles	119
Infectious and non-infectious precipitants of sarcoidosis	96
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors	93
GILZ regulates type I interferon release and sequesters STAT1	91
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression	85
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination	84
Nuclear translocation of RIG-I promotes cellular apoptosis	83
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis	75
Post COVID-19 hospitalizations in patients with chronic inflammatory diseases – A nationwide cohort study	74
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	71
miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases	70
Editorial Board	69
Editorial Board	68
Editorial Board	67
Editorial Board	67
Editorial Board	65
Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis	58
Editorial Board	57
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile	57
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination	55

Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease	55
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	54
Impact of coding risk variant IFNGR2 on the B cell-intrinsic IFN-γ signaling pathway in multiple sclerosis	53
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells	51
VNN2-expressing circulating monocytes exhibit unique functional characteristics and are decreased in patients with primary Sjögren's syndrome	49
Reconstituted CD74+ NK cells trigger chronic graft versus host disease after allogeneic bone marrow transplantation	49
Editorial Board	48
Editorial Board	47
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis	47
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak	46
Advances in SLE classification criteria	46
Adding salt to foods and risk of psoriasis: A prospective cohort study	46
UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus	45
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis	45
Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis	44
Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors	41
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?	39
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial	39
Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice	39
Autoreactive memory Th17 cells are principally derived from T-bet+RORγt+ Th17/1 effectors	38
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network	37
Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis	36
Application of laboratory models for sarcoidosis research	35
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	34
CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis	34
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?	34
COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study	33
Single cell transcriptomic analysis of Graves’ disease thyroid glands reveals the broad immunoregulatory potential of thyroid follicular and stromal cells and implies a major re-interpretation of the	32
Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis	32
Natural IgG protects against early dissemination of vesicular stomatitis virus	30
Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases	30
CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus	30
EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification	29
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation	29
Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance	28
High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis	28
Balancing efficacy and safety of complement inhibitors	28
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus	27
Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients	27
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	26
A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells	26
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients	26
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis	25
Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage	25
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination	25
Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy	25
Telomeres: New players in immune-mediated inflammatory diseases?	24
Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) Program	24
Neural autoantibodies in delirium	24
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis	24

Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression	24
Pulmonary sarcoidosis: A comprehensive review: Past to present	23
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients	23
Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis	22
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications	22
Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's disease	21
CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties	21
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials	21
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	20
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets	20
Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination	20
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data	19
Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis	19
Corrigendum to “Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis” [J. Autoimmun. 119C (2021) 102629]	19
Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome	19
Compositional and functional aberrance of the gut microbiota in treatment naïve patients with primary Sjögren's syndrome [J. Autoimmun., 134, January 2023, 102958]	19
T helper cell immunity in pregnancy and influence on autoimmune disease progression	18
Transcriptomic profiling of iris tissue highlights LCK signaling and T cell-mediated immunity in Behcet's uveitis	18
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma	18
Signal responses to neutral TSH receptor antibody – A cycle of damage in the pathophysiology of Graves’ disease	18
Editorial Board	17
Editorial Board	17
Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis	17
Cognitive dysfunction in SLE: An understudied clinical manifestation	17
Editorial Board	17
Editorial Board	17
Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus	17
Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features	17
COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases	17
In cis “benign” SOCS1 variants linked to enhanced interferon signaling and autoimmunity	17
Long-term (16–26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss	17
Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis	16
Evidence for charge-based mimicry in anti dsDNA antibody generation	16
Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis	16
Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls	16
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease	16
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity	16
Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models	15
Antigen-specific T cells and autoimmunity	15
Antimyeloperoxidase antibodies modulate inflammatory responses and activate profibrotic pathways in human monocytes	15
Molecular signature of neutrophil extracellular trap mediating disease module in idiopathic inflammatory myopathy	15
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	15
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases	15
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	15
Hoigné’s syndrome, an uncommon mimicker of anaphylaxis: Systematic literature review	14
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	14
Developmental drugs for sarcoidosis	14
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)	14
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells	14
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice	14
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application	13
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination	13
Erratum to “Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial” [J. Autoimmun. 130, June 2022, 102844]	13
Chronic inflammation in high-fat diet-fed mice: Unveiling the early pathogenic connection between liver and adipose tissue	13
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases	13
Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis	13
Corrigendum to “Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies” [J. Autoimmun. 126 (2022) 102774]	13
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk	12
Lupus nephritis: new progress in diagnosis and treatment	12
Salivary gland epithelial cell in Sjögren's syndrome: Metabolic shift and altered mitochondrial morphology toward an innate immune cell function	12
Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis	12
Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes	12
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p	12
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	12
Wiskott–Aldrich syndrome protein maintains regulatory T cell tolerance by modulating their surface IL-2 receptor levels	12
ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP	12